PRDX1 as a Redox Gatekeeper at Mitochondrial-ER Contact Sites: Implications for Kidney Fibrosis Progression and Therapy.

Zhang Y, Lee J, Yu NN, Jin MH, Han YH, Park HJ, Koo DB, Sun HN, Lee DS

Open source

DOI
10.3390/antiox15101263
Published
2026 Oct 1
Container
Antioxidants (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antiox15101263,
  title = {PRDX1 as a Redox Gatekeeper at Mitochondrial-ER Contact Sites: Implications for Kidney Fibrosis Progression and Therapy.},
  author = {Zhang Y and Lee J and Yu NN and Jin MH and Han YH and Park HJ and Koo DB and Sun HN and Lee DS},
  year = {2026},
  journal = {Antioxidants (Basel, Switzerland)},
  doi = {10.3390/antiox15101263},
  url = {https://doi.org/10.3390/antiox15101263}
}

RIS

TY  - JOUR
TI  - PRDX1 as a Redox Gatekeeper at Mitochondrial-ER Contact Sites: Implications for Kidney Fibrosis Progression and Therapy.
AU  - Zhang Y
AU  - Lee J
AU  - Yu NN
AU  - Jin MH
AU  - Han YH
AU  - Park HJ
AU  - Koo DB
AU  - Sun HN
AU  - Lee DS
PY  - 2026
JO  - Antioxidants (Basel, Switzerland)
DO  - 10.3390/antiox15101263
UR  - https://doi.org/10.3390/antiox15101263
ER  - 

APA

Y, Z., J, L., NN, Y., MH, J., YH, H., HJ, P., DB, K., HN, S., & DS, L. (2026). PRDX1 as a Redox Gatekeeper at Mitochondrial-ER Contact Sites: Implications for Kidney Fibrosis Progression and Therapy.. Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox15101263

Source records